125 related articles for article (PubMed ID: 35781730)
41. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
Jankowska A; Młyńczak K; Golicki D
Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
[TBL] [Abstract][Full Text] [Related]
42. Application of EQ-5D-5L questionnaire in patients suffering from urinary incontinence.
Garcia-Gordillo MA; Collado-Mateo D; Olivares PR; Adsuar JC
Actas Urol Esp; 2016 Sep; 40(7):457-62. PubMed ID: 26975979
[TBL] [Abstract][Full Text] [Related]
43. Health utility reporting in chronic rhinosinusitis patients.
Bewick J; Morris S; Hopkins C; Erskine S; Philpott CM
Clin Otolaryngol; 2018 Feb; 43(1):90-95. PubMed ID: 28498517
[TBL] [Abstract][Full Text] [Related]
44. Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial.
Xie J; Wang Y; Xu Y; Fine JT; Lam J; Garrison LP
J Med Econ; 2022; 25(1):51-58. PubMed ID: 34907813
[TBL] [Abstract][Full Text] [Related]
45. Quality assessment using EQ-5D-5L after lung surgery for non-small cell lung cancer (NSCLC) patients.
Koide R; Kikuchi A; Miyajima M; Mishina T; Takahashi Y; Okawa M; Sawada I; Nakajima J; Watanabe A; Mizuguchi T
Gen Thorac Cardiovasc Surg; 2019 Dec; 67(12):1056-1061. PubMed ID: 31098867
[TBL] [Abstract][Full Text] [Related]
46. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K
Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419
[TBL] [Abstract][Full Text] [Related]
47. Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged "no-problems".
Murasawa H; Sugiyama T; Matsuoka Y; Okabe T; Wakumoto Y; Tanaka N; Sugimoto M; Oyama M; Fujimoto K; Horie S; Funagoshi M; Arakawa I; Noto S; Shimozuma K
Qual Life Res; 2020 Mar; 29(3):755-763. PubMed ID: 31583618
[TBL] [Abstract][Full Text] [Related]
48. Trajectory and profile of quality of life in patients undergoing lung resection for lung cancer during hospitalization according to the EQ-5D.
Ichimura H; Kobayashi K; Gosho M; Nakaoka K; Yanagihara T; Ueda S; Saeki Y; Araki K; Kawamura T; Sato Y
Gen Thorac Cardiovasc Surg; 2021 Aug; 69(8):1204-1213. PubMed ID: 33608836
[TBL] [Abstract][Full Text] [Related]
49. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway.
Aas CF; Vold JH; Skurtveit S; Lim AG; Ruths S; Islam K; Askildsen JE; Løberg EM; Fadnes LT; Johansson KA;
Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):68. PubMed ID: 32883319
[TBL] [Abstract][Full Text] [Related]
50. Assessing health-related quality of life of patients with colorectal cancer using EQ-5D-5L: a cross-sectional study in Heilongjiang of China.
Huang W; Yang J; Liu Y; Liu C; Zhang X; Fu W; Shi L; Liu G
BMJ Open; 2018 Dec; 8(12):e022711. PubMed ID: 30530472
[TBL] [Abstract][Full Text] [Related]
51. Inequality and heterogeneity in health-related quality of life: findings based on a large sample of cross-sectional EQ-5D-5L data from the Swedish general population.
Teni FS; Gerdtham UG; Leidl R; Henriksson M; Åström M; Sun S; Burström K
Qual Life Res; 2022 Mar; 31(3):697-712. PubMed ID: 34628587
[TBL] [Abstract][Full Text] [Related]
52. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
[TBL] [Abstract][Full Text] [Related]
53. Investigating the Added Value of the EQ-5D-5L With Two Bolt-On Items in Patients With Hemophilia.
Xu RH; Dong D; Luo N; Yang R; Liu J; Zhang S
Front Med (Lausanne); 2021; 8():707998. PubMed ID: 34422863
[No Abstract] [Full Text] [Related]
54. Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
Hagiwara Y; Shiroiwa T; Taira N; Kawahara T; Konomura K; Noto S; Fukuda T; Shimozuma K
Health Qual Life Outcomes; 2020 Nov; 18(1):354. PubMed ID: 33143687
[TBL] [Abstract][Full Text] [Related]
55. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
Feng Y; Devlin N; Herdman M
Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
[TBL] [Abstract][Full Text] [Related]
56. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
[TBL] [Abstract][Full Text] [Related]
57. Health related quality of life aspects not captured by EQ-5D-5L: Results from an international survey of patients.
Efthymiadou O; Mossman J; Kanavos P
Health Policy; 2019 Feb; 123(2):159-165. PubMed ID: 30598239
[TBL] [Abstract][Full Text] [Related]
58. Health-Related Quality of Life of Patients with HIV/AIDS in Bogotá, Colombia.
Keaei M; Kuhlmann J; Conde R; Evers SM; Gonzalez J; Govers M; Hiligsmann M
Value Health Reg Issues; 2016 Dec; 11():68-72. PubMed ID: 27986201
[TBL] [Abstract][Full Text] [Related]
59. Validity of the EQ-5D in patients with pemphigus vulgaris and pemphigus foliaceus.
Tamási B; Brodszky V; Péntek M; Gulácsi L; Hajdu K; Sárdy M; Szegedi A; Bata-Csörgő Z; Kinyó Á; Rencz F
Br J Dermatol; 2019 Apr; 180(4):802-809. PubMed ID: 29897626
[TBL] [Abstract][Full Text] [Related]
60. Validity of EQ-5D-5L in stroke.
Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
